DADC
SGYP

D.A. Davidson & Co’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

D.A. Davidson & Co’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-141,053
Closed -$315K – 1168
2017
Q4 		$315K Sell
141,053
-12,469
-8% -$31K 0.01% 825
2017
Q3 		$445K Hold
153,522
– – 0.01% 716
2017
Q2 		$683K Sell
153,522
-5,847
-4% -$24.1K 0.02% 538
2017
Q1 		$742K Sell
159,369
-355
-0.2% -$2.06K 0.02% 508
2016
Q4 		$972K Sell
159,724
-3,644
-2% -$19K 0.02% 474
2016
Q3 		$900K Buy
163,368
+30,080
+23% +$141K 0.02% 485
2016
Q2 		$506K Buy
+133,288
New +$452K 0.01% 537

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

D.A. Davidson & Co's SGYP Position: Q1 2018 in Review

D.A. Davidson & Co sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2018, closing a stake of 141,053 shares — an estimated $315K sold.

D.A. Davidson & Co first reported a position in SGYP in Q2 2016 and held it in 7 quarters. The position peaked at $972K in Q4 2016. 147 funds tracked by Wall St. Rank hold SGYP as of Q1 2018.

  • D.A. Davidson & Co reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2018 after selling out during the quarter.
  • D.A. Davidson & Co sold 141,053 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2018, an estimated $315K.
  • D.A. Davidson & Co first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2016 and held it in 7 quarters.
  • D.A. Davidson & Co's Synergy Pharmaceuticals, Inc Common Stock position peaked at $972K in Q4 2016.
  • 147 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2018.

Based on D.A. Davidson & Co's 13F filing for Q1 2018, filed 4 May 2018.